Greenland Mines Stock (NASDAQ:GRML)

Financials Chart

Previous Close

$3.26

52W Range

$0.16 - $9.71

50D Avg

$0.41

200D Avg

$0.41

Market Cap

$9.42M

Avg Vol (3M)

$10.33M

Beta

2.48

Div Yield

-

GRML Company Profile

Greenland Mines Ltd operates across two segments: natural resources and cell and gene therapy. Its resources arm is focused on exploring for palladium, gold, and platinum, centered on the exploration and development of the Skaergaard project in Southeast Greenland. On the therapeutics side, the company is developing KLTO-202, a gene therapy targeting the treatment and prevention of amyotrophic lateral sclerosis (ALS), and KLTO-101, aimed at treating or preventing Alzheimer's disease, alongside therapies for Parkinson's and other age-related conditions. Previously known as Klotho Neurosciences, Inc., the company adopted its current name in March 2026. It is headquartered in Charlotte, North Carolina.

Industry

Other Precious Metals

Sector

Basic Materials

Exchange

NASDAQ

ADR

-

Country

US

Employees

5

IPO Date

Apr 29, 2022

Website

GRML Performance

GRML Financial Summary

	Dec 25	Dec 24	Dec 23
Revenue	-	-	-
Operating Income	$-7.15M	$-5.54M	$-631.32K
Net Income	$-10.55M	$-6.15M	$-707.46K
EBITDA	$-7.15M	$-5.54M	$-631.32K
Basic EPS	$-0.22	$-0.32	$-0.05
Diluted EPS	$-0.22	$-0.32	$-0.05

Fiscal year ends in Dec 25 | Currency in USD